{"content":"<li class=\"n-box-item date-title\" data-end=\"1489723199\" data-start=\"1489636800\" data-txt=\"Sunday, December 22, 2019\">Thursday, March 16, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3251867\" data-ts=\"1489703123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VUZI\" target=\"_blank\">VUZI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251867-vuzixminus-4_2-after-hours-notes-material-weakness-ongoing-of-december-2016\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vuzix -4.2% after hours, notes material weakness ongoing as of December 2016</a></h4><ul><li>Vuzix&nbsp;<a href=\"https://seekingalpha.com/filing/3464245#V461282_10K_HTM_A_003\" target=\"_blank\">observes</a>, through preparation of financial statements, existence of ineffective disclosure controls and procedures and internal reporting controls as of December 31, 2016, items prospectively causative of future material misstatements. Vuzix (NASDAQ:<a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corp'>VUZI</a>) $6.90 after hours.</li><li><a href=\"https://seekingalpha.com/filing/3464245\" target=\"_blank\">10-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251867\" data-linked=\"Vuzix -4.2% after hours, notes material weakness ongoing as of December 2016\" data-tweet=\"$VUZI - Vuzix -4.2% after hours, notes material weakness ongoing as of December 2016 https://seekingalpha.com/news/3251867-vuzixminus-4_2-after-hours-notes-material-weakness-ongoing-of-december-2016?source=tweet\" data-url=\"https://seekingalpha.com/news/3251867-vuzixminus-4_2-after-hours-notes-material-weakness-ongoing-of-december-2016\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251866\" data-ts=\"1489702662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RYN\" target=\"_blank\">RYN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251866-rayonier-buys-217m-in-southern-coastal-timberlands-to-offer-5m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rayonier buys $217M in southern coastal timberlands, to offer 5M shares</a></h4><ul><li>Rayonier (NYSE:<a href='https://seekingalpha.com/symbol/RYN' title='Rayonier Inc.'>RYN</a>) <font color='red'>-3%</font>&nbsp;AH after <a href=\"https://seekingalpha.com/pr/16773957-rayonier-announces-acquisitions-u-s-south-coastal-atlantic-markets\" target=\"_blank\">agreeing to acquire</a> ~95,100 acres of high-quality industrial timberlands in the southeastern U.S. for a combined $217M.</li><li>RYN says the Acquisitions are comprised of highly productive timberlands  located in some of the strongest timber markets in the South,  primarily along the I-95 coastal corridor near Savannah, Ga.</li><li>To help fund the deal, RYN launches a <a href=\"https://seekingalpha.com/pr/16773960-rayonier-announces-proposed-offering-common-shares\" target=\"_blank\">public offering</a> of 5M common shares, with an underwriters option to purchase up to an additional 750K shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251866\" data-linked=\"Rayonier buys $217M in southern coastal timberlands, to offer 5M shares\" data-tweet=\"$RYN - Rayonier buys $217M in southern coastal timberlands, to offer 5M shares https://seekingalpha.com/news/3251866-rayonier-buys-217m-in-southern-coastal-timberlands-to-offer-5m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3251866-rayonier-buys-217m-in-southern-coastal-timberlands-to-offer-5m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251865\" data-ts=\"1489701536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251865-valeant-pharma-jumps-ah-valueact-adds-3m-shares-to-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant Pharma jumps AH as ValueAct adds 3M shares to stake</a></h4><ul>     <li>Valeant Pharmaceuticals (VRX) <font color='green'>+4.3%</font> AH on news that ValueAct Capital bought another 3M shares in the company, according to a <a href=\"https://www.sec.gov/Archives/edgar/data/885590/000141881217000025/vrx13d031617.txt\" target=\"_blank\">13D filing</a>.</li>     <li>The purchase brings ValueAct's stake in VRX to nearly 18M shares, or 5.2%, making it the company's second largest shareholder after Paulson  &amp; Co., which owns 5.68%.</li>          <li>ValueAct purchased its shares on March 14 at $10.81-$10.88 and follows Bill Ackman's recent liquidation of his position.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251865\" data-linked=\"Valeant Pharma jumps AH as ValueAct adds 3M shares to stake\" data-tweet=\"$BHC - Valeant Pharma jumps AH as ValueAct adds 3M shares to stake https://seekingalpha.com/news/3251865-valeant-pharma-jumps-ah-valueact-adds-3m-shares-to-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3251865-valeant-pharma-jumps-ah-valueact-adds-3m-shares-to-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>130&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251861\" data-ts=\"1489700111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251861-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/AVXS' title='AveXis'>AVXS</a> <font color='green'>+11.3%</font>. <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='green'>+7.3%</font>. <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+6.0%</font>. <a href='https://seekingalpha.com/symbol/FATE' title='Fate Therapeutics, Inc.'>FATE</a> <font color='green'>+5.6%</font>. <a href='https://seekingalpha.com/symbol/FRSH' title='Papa Murphy&#39;s Holdings, Inc.'>FRSH</a> <font color='green'>+4.7%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='red'>-8.6%</font>. AOI <font color='red'>-7.2%</font>. <a href='https://seekingalpha.com/symbol/RST' title='Rosetta Stone Inc.'>RST</a> <font color='red'>-6.0%</font>. <a href='https://seekingalpha.com/symbol/SXC' title='SunCoke Energy'>SXC</a> <font color='red'>-5.8%</font>. <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color='red'>-5.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251861\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AVXS $VSLR $OMER - After Hours Gainers / Losers https://seekingalpha.com/news/3251861-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3251861-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251822\" data-ts=\"1489696156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOFG\" target=\"_blank\">MOFG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251822-midwestone-financialminus-5-on-share-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MidWestOne Financial -5% on share sale</a></h4><ul><li>A trust controlled by board Chairman John Morrison <a href=\"https://seekingalpha.com/pr/16773950-midwestone-financial-group-inc-announces-launch-public-offering-common-stock\" target=\"_blank\">is selling stock</a> (amount not disclosed). The company will receive no proceeds from the sale.</li><li><a href='https://seekingalpha.com/symbol/MOFG' title='MidWestOne Financial Group, Inc.'>MOFG</a>&nbsp;<font color='red'>-5.1%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3251822\" data-linked=\"MidWestOne Financial -5% on share sale\" data-tweet=\"$MOFG - MidWestOne Financial -5% on share sale https://seekingalpha.com/news/3251822-midwestone-financialminus-5-on-share-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3251822-midwestone-financialminus-5-on-share-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251820\" data-ts=\"1489696007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251820-adobe-systemsplus-4_2-q1-2017-forecasts-positive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adobe Systems +4.2%; Q1 2017, forecasts positive</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3251792-adobe-systems-beats-0_07-beats-revenue\" target=\"_blank\">Q1 2017 results</a></strong> &ndash; revenue $1.68B (+21.7% Y/Y,&nbsp;<font color='green'>$30M above estimates</font>), EPS $0.94 (<font color='green'>$0.07 above estimates</font>), Digital Media revenue $1.14B, Creative revenue $942M, Digital Media ARR [annualized recurring revenue] $4.25B (+$265M sequentially), Adobe Marketing Cloud revenue $477M, operating income +40% Y/Y, net income +42% Y/Y, cash flow from operations $730M, deferred revenue $2.1B, share repurchases $238M (2.2M shares)</li><li><strong><a href=\"http://wwwimages.adobe.com/content/dam/Adobe/en/investor-relations/PDFs/61307102/dn3Elz1O8hgs.pdf\" target=\"_blank\">Q2 2017 projections</a></strong> &ndash; revenue $1.73B (<a href=\"https://finance.yahoo.com/quote/ADBE/analysts?p=ADBE\" target=\"_blank\">consensus $1.72B</a>), EPS $0.94 (consensus $0.91), non-operating other expense $15M, tax rate 21%, share count 499M</li><li><strong>After hours</strong> &ndash; (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) $127.50</li><li><a href=\"https://seekingalpha.com/pr/16773924-adobe-reports-record-revenue\" target=\"_blank\">Press release</a> / <a href=\"http://www.adobe.com/investor-relations/earnings-call.html\" target=\"_blank\">conference call</a> / <a href=\"http://wwwimages.adobe.com/content/dam/Adobe/en/investor-relations/PDFs/61307102/bL0uHb34gQd3.pdf\" target=\"_blank\">earnings slides</a> / <a href=\"http://wwwimages.adobe.com/content/dam/Adobe/en/investor-relations/PDFs/61307102/cy8KwC40zQld.pdf\" target=\"_blank\">data sheet</a> / <a href=\"https://seekingalpha.com/filing/3463582\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251820\" data-linked=\"Adobe Systems +4.2%; Q1 2017, forecasts positive\" data-tweet=\"$ADBE - Adobe Systems +4.2%; Q1 2017, forecasts positive https://seekingalpha.com/news/3251820-adobe-systemsplus-4_2-q1-2017-forecasts-positive?source=tweet\" data-url=\"https://seekingalpha.com/news/3251820-adobe-systemsplus-4_2-q1-2017-forecasts-positive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251818\" data-ts=\"1489695542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVXS\" target=\"_blank\">AVXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251818-avexis-misses-0_12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AveXis misses by $0.12</a></h4><ul><li>AveXis (NASDAQ:<a href='https://seekingalpha.com/symbol/AVXS' title='AveXis'>AVXS</a>): Q4 EPS of -$0.92 <font color='red'>misses by $0.12</font>.</li><li><a href=\"https://seekingalpha.com/pr/16773932-avexis-reports-topline-results-phase-1-trial-avxsminus-101-sma-type-1-fourth-quarter-full\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251818\" data-linked=\"AveXis misses by $0.12\" data-tweet=\"$AVXS - AveXis misses by $0.12 https://seekingalpha.com/news/3251818-avexis-misses-0_12?source=tweet\" data-url=\"https://seekingalpha.com/news/3251818-avexis-misses-0_12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251792\" data-ts=\"1489694777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251792-adobe-systems-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adobe Systems beats by $0.07, beats on revenue</a></h4><ul><li>Adobe Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>): FQ1 EPS of $0.94 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $1.68B (+21.7% Y/Y) <font color='green'>beats by $30M</font>.</li><li>Shares <font color='green'>+1.3%</font>.</li><li><a href='https://seekingalpha.com/pr/16773924-adobe-reports-record-revenue'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251792\" data-linked=\"Adobe Systems beats by $0.07, beats on revenue\" data-tweet=\"$ADBE - Adobe Systems beats by $0.07, beats on revenue https://seekingalpha.com/news/3251792-adobe-systems-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3251792-adobe-systems-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251788\" data-ts=\"1489694648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251788-mannkind-beats-0_76-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MannKind beats by $0.76, beats on revenue</a></h4><ul><li>MannKind (NASDAQ:<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a>): Q4 EPS of $0.56 <font color='green'>beats by $0.76</font>.</li><li>Revenue of $12.4M <font color='green'>beats by $6.4M</font>.</li><li>Shares <font color='green'>+6.3%</font>.</li><li><a href='https://seekingalpha.com/pr/16773905-mannkind-corporation-reports-2016-fourth-quarter-full-year-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251788\" data-linked=\"MannKind beats by $0.76, beats on revenue\" data-tweet=\"$MNKD - MannKind beats by $0.76, beats on revenue https://seekingalpha.com/news/3251788-mannkind-beats-0_76-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3251788-mannkind-beats-0_76-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251786\" data-ts=\"1489694589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSBR\" target=\"_blank\">CSBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251786-champions-oncology-reports-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Champions Oncology reports Q4 results</a></h4><ul><li>Champions Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CSBR' title='Champions Oncology, Inc.'>CSBR</a>): Q4 EPS of -$0.11</li><li>Revenue of $3.57M (+40.0% Y/Y)</li><li>Shares <font color='green'>+1.6%</font>.</li><li><a href='https://seekingalpha.com/pr/16773898-champions-oncology-reports-40-percent-revenue-growth'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251786\" data-linked=\"Champions Oncology reports Q4 results\" data-tweet=\"$CSBR - Champions Oncology reports Q4 results https://seekingalpha.com/news/3251786-champions-oncology-reports-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3251786-champions-oncology-reports-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251781\" data-ts=\"1489694341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251781-jmp-securities-upgrades-oracle-from-underperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JMP Securities upgrades Oracle from Underperform</a></h4><ul><li>Amid <a href=\"https://www.tipranks.com/stocks/orcl\" target=\"_blank\">assorted</a> price target raises and buy-equivalent rating reiterations (as well as an upgrade to Overweight at J.P. Morgan) subsequent Oracle's (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>) Q3 2017 reporting indicating strength in cloud segments, JMP Securities analyst Patrick&nbsp;Walravens modifies view from negative, though notes concerns persist over auditing tactics, customer satisfaction rates and cloud competition.</li><li>Additionally factors SaaS/PaaS unit scale that's nearing that of the company's declining new license business and Oracle's valuation gap (15x&nbsp;CY18 P/E multiple)&nbsp;relative to Microsoft (19x), SAP (21x), Adobe Systems (25x) and elsewhere. Given share gains of&nbsp;<font color='green'>roughly 6%</font>&nbsp;post-earnings, considers present trade levels fair value.</li><li>Previously (March 15, 2017): <a href=\"https://seekingalpha.com/news/3251486-oracle-plus-3_4-percent-q3-2017-cloud-performance-headlines-dividend-raised\" target=\"_blank\">Oracle +3.4%; Q3 2017 cloud performance headlines, dividend raised</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251781\" data-linked=\"JMP Securities upgrades Oracle from Underperform\" data-tweet=\"$ORCL - JMP Securities upgrades Oracle from Underperform https://seekingalpha.com/news/3251781-jmp-securities-upgrades-oracle-from-underperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3251781-jmp-securities-upgrades-oracle-from-underperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251779\" data-ts=\"1489694087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INNL\" target=\"_blank\">INNL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251779-innocoll-in-talks-potential-suitor-shares-ahead-42\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Innocoll in talks with potential suitor; shares ahead 42%</a></h4><ul><li>Innocoll Holdings (<a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='green'>+41.7%</font>) heads north on a 13x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16773714-innocoll-holdings-announces-statement-re-possible-offer\" target=\"_blank\">announcement </a>that it is in discussions with an unnamed party concerning a possible acquisition.</li><li>The company has struggled to get products to the marketplace. It received a CRL in December 2016 from the FDA in response to its XARACOLL marketing application. A month before that, it announced that INL-002 failed to beat standard-of-care treatment in two late-stage studies in patients with diabetic foot ulcers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251779\" data-linked=\"Innocoll in talks with potential suitor; shares ahead 42%\" data-tweet=\"$INNL - Innocoll in talks with potential suitor; shares ahead 42% https://seekingalpha.com/news/3251779-innocoll-in-talks-potential-suitor-shares-ahead-42?source=tweet\" data-url=\"https://seekingalpha.com/news/3251779-innocoll-in-talks-potential-suitor-shares-ahead-42\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251775\" data-ts=\"1489692524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251775-avian-flu-hits-second-tennessee-breeder-farm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avian flu hits second Tennessee breeder farm</a></h4><ul>     <li>The Tennessee Department of Agriculture says a second commercial chicken farm in the state has been <a href=\"https://www.bloomberg.com/news/articles/2017-03-16/bird-flu-reaches-another-tennessee-chicken-farm-linked-to-tyson\" target=\"_blank\">hit </a>with the highly-pathogenic avian influenza</li>     <li>The flock at the location tested positive on March 14.</li><li>The breeder farm is a supplier for Tyson Foods (<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a> <font color='red'>-1.9%</font>).</li><li><a href=\"https://www.tn.gov/agriculture/news/49265\" target=\"_blank\">Tennessee Department of Agriculture statement</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3251775\" data-linked=\"Avian flu hits second Tennessee breeder farm\" data-tweet=\"$TSN - Avian flu hits second Tennessee breeder farm https://seekingalpha.com/news/3251775-avian-flu-hits-second-tennessee-breeder-farm?source=tweet\" data-url=\"https://seekingalpha.com/news/3251775-avian-flu-hits-second-tennessee-breeder-farm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251773\" data-ts=\"1489692066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251773-gopro-upgraded-from-sell-to-neutral-citi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro upgraded from Sell to Neutral at Citi</a></h4><ul><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Citi+Upgrades+GoPro+%28GPRO%29+to+Neutral/12674448.html\" target=\"_blank\">Firm cites</a> revenue stabilization and major restructuring as likely accelerating timeline for profitability, while also considering the risk of GoPro (<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='green'>+14%</font>) accessing its credit facility as reduced. Price target $9 (current price $8.36).</li><li>Yesterday (March 15, 2017): <a href=\"https://seekingalpha.com/news/3251451-gopro-plus-10_3-percent-q1-2017-revenue-expected-top-end-guidance-fy-2017-profitability\" target=\"_blank\">GoPro +10.3%; Q1 2017 revenue expected at top end of guidance, FY 2017 profitability target reiterated, restructuring planned</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251773\" data-linked=\"GoPro upgraded from Sell to Neutral at Citi\" data-tweet=\"$GPRO - GoPro upgraded from Sell to Neutral at Citi https://seekingalpha.com/news/3251773-gopro-upgraded-from-sell-to-neutral-citi?source=tweet\" data-url=\"https://seekingalpha.com/news/3251773-gopro-upgraded-from-sell-to-neutral-citi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251771\" data-ts=\"1489691829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCRB\" target=\"_blank\">MCRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251771-seres-on-go-late-stage-study-of-lead-product-candidate-to-prevent-recurrent-c-diff-infections\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seres on go with late-stage study of lead product candidate to prevent recurrent C. diff infections; shares ahead 34%</a></h4><ul><li>Thinly traded micro cap Seres Therapeutics (<a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics'>MCRB</a> <font color='green'>+34.4%</font>) heads north on a healthy 26x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16772954-seres-therapeutics-reports-fourth-quarter-full-year-2016-financial-results-provides\" target=\"_blank\">announcement</a> that plans to initiate a Phase 3 clinical trial, ECOSPOR III, evaluating lead product candidate, Breakthrough Therapy- and Orphan Drug-tagged SER-109, for the prevention of recurrent <em>Clostridium difficile</em> (<em>C. diff</em>) infections.</li><li>The FDA has agreed that this trial could support a regulatory application.</li><li><a href=\"http://www.serestherapeutics.com/pipeline/ser-109\" target=\"_blank\">SER-109</a>&nbsp;is a single-dose capsule containing an ecology of bacterial spores enriched and purified from healthy screened human donors. Its keystone organisms address the underlying dysbiosis and returns the microbiome to a healthy state.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3239099-seres-therapeutics-lead-product-candidate-shows-positive-effect-mid-stage-c-diff-study-shares\" target=\"_blank\">Seres Therapeutics' lead product candidate shows positive effect in mid-stage C. diff study; shares ahead 10% premarket</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3251771\" data-linked=\"Seres on go with late-stage study of lead product candidate to prevent recurrent C. diff infections; shares ahead 34%\" data-tweet=\"$MCRB - Seres on go with late-stage study of lead product candidate to prevent recurrent C. diff infections; shares ahead 34% https://seekingalpha.com/news/3251771-seres-on-go-late-stage-study-of-lead-product-candidate-to-prevent-recurrent-c-diff-infections?source=tweet\" data-url=\"https://seekingalpha.com/news/3251771-seres-on-go-late-stage-study-of-lead-product-candidate-to-prevent-recurrent-c-diff-infections\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251772\" data-ts=\"1489691791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSIQ\" target=\"_blank\">CSIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251772-canadian-solar-signs-ppas-for-solar-projects-in-india\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Solar signs PPAs for solar projects in India</a></h4><ul><li>Canadian Solar (<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='green'>+2.4%</font>) <a href=\"https://seekingalpha.com/pr/16770110-canadian-solar-signs-ppas-solar-energy-corporation-india-seci-develop-80-mwac-solar-power\" target=\"_blank\">signs 25-year  power purchase agreements</a> for 80 MW of solar power  projects in the Indian state of Maharashtra with the Solar Energy  Corp. of India, the government&rsquo;s corporate solar arm.</li><li>CSIQ says it was awarded the projects  under a 450 MWac solar capacity tender in the state of Maharashtra  through a competitive auction process; the projects are scheduled to  begin operations by late 2017.</li><li>CSIQ&rsquo;s Indian pipeline now stands at 110 MWac,  which CEO Shawn Qu says represents a &ldquo;significant  milestone in one of the world&rsquo;s fastest-growing renewables markets.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3251772\" data-linked=\"Canadian Solar signs PPAs for solar projects in India\" data-tweet=\"$CSIQ - Canadian Solar signs PPAs for solar projects in India https://seekingalpha.com/news/3251772-canadian-solar-signs-ppas-for-solar-projects-in-india?source=tweet\" data-url=\"https://seekingalpha.com/news/3251772-canadian-solar-signs-ppas-for-solar-projects-in-india\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251768\" data-ts=\"1489690823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251768-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IPAS' title='IPASS INC'>IPAS</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/INVE' title='Identiv, Inc.'>INVE</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ISNS' title='Image Sensing Systems, Inc.'>ISNS</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/VLTC' title='Voltari Corporation'>OTC:VLTC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/NTIP' title='Network-1 Technologies, Inc.'>NTIP</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251768\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$IPAS $NH $IPDN - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3251768-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3251768-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251767\" data-ts=\"1489690629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251767-session-loss-for-euro-disappears-after-ecb-member-talks-rate-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Session loss for euro disappears after ECB member talks rate hike</a></h4><ul><li>A rate increase could be on the way, <a href=\"https://global.handelsblatt.com/finance/austrian-ecb-council-member-rate-increase-could-be-on-the-way-728696\" target=\"_blank\">says ECB Governing Council member</a> Ewald Nowotny (from Austria).</li><li>Of particular interest, he says the ECB could do the opposite of the Fed, and increase benchmark rates before ending QE.</li><li>Down for most of the session, the euro (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a>) has jumped about 30 pips, now&nbsp;<font color='green'>higher by 0.1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a>, <a href='https://seekingalpha.com/symbol/EUO' title='ProShares UltraShort Euro ETF'>EUO</a>, <a href='https://seekingalpha.com/symbol/ERO' title='iPath EUR/USD Exchange Rate ETN'>ERO</a>, <a href='https://seekingalpha.com/symbol/DRR' title='Market Vectors Double Short Euro ETN'>DRR</a>, <a href='https://seekingalpha.com/symbol/ULE' title='ProShares Ultra Euro ETF'>ULE</a>, <a href='https://seekingalpha.com/symbol/EUFX' title='ProShares Short Euro ETF'>EUFX</a>, <a href='https://seekingalpha.com/symbol/URR' title='Market Vectors Double Long Euro ETN'>URR</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251767\" data-linked=\"Session loss for euro disappears after ECB member talks rate hike\" data-tweet=\"$FXE $EUO $ERO - Session loss for euro disappears after ECB member talks rate hike https://seekingalpha.com/news/3251767-session-loss-for-euro-disappears-after-ecb-member-talks-rate-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3251767-session-loss-for-euro-disappears-after-ecb-member-talks-rate-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251762\" data-ts=\"1489688731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251762-snap-falls-below-20-for-first-time\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap falls below $20 for first time</a></h4><ul><li>Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) is&nbsp;<font color='red'>down 4.38%</font>&nbsp;to slip below $20 for the first time since the IPO.</li><li>TheStreet.com <a href=\"https://www.thestreet.com/story/14045772/1/snap-holders-eye-lawsuits-in-ipo-s-wake.html\" target=\"_blank\">reported</a> earlier today that Snap could face some investor lawsuits over the high level of non-voting shares issued as part of the public launch.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251762\" data-linked=\"Snap falls below $20 for first time\" data-tweet=\"$SNAP - Snap falls below $20 for first time https://seekingalpha.com/news/3251762-snap-falls-below-20-for-first-time?source=tweet\" data-url=\"https://seekingalpha.com/news/3251762-snap-falls-below-20-for-first-time\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>99&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251760\" data-ts=\"1489687443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMK\" target=\"_blank\">WMK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251760-grocery-store-stocks-extend-post-cpi-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery store stocks extend post-CPI gains</a></h4><ul><li>Grocery store stocks continue to rally after yesterday's report on consumer prices showed a drop in food prices (-1.1% Y/Y).</li><li>A larger gap between grocery store prices and restaurant menu prices helps stoke demand for the chains.</li><li>Gainers include Weis Markets (<a href='https://seekingalpha.com/symbol/WMK' title='Weis Markets Inc'>WMK</a> <font color='green'>+1.7%</font>), Whole Foods Market (WFM <font color='green'>+1.3%</font>), Sprouts Farmers Market (<a href='https://seekingalpha.com/symbol/SFM' title='Sprouts Farmers Market'>SFM</a> <font color='green'>+5.6%</font>), Kroger (<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a> <font color='green'>+1.7%</font>) and Ingles Markets (<a href='https://seekingalpha.com/symbol/IMKTA' title='Ingles Markets, Incorporated'>IMKTA</a> <font color='green'>+0.9%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3251251-core-cpi-rises-line-forecasts\" target=\"_blank\">Core CPI rises in-line with forecasts</a> (March 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3251760\" data-linked=\"Grocery store stocks extend post-CPI gains\" data-tweet=\"$WMK $WMK $AMZN - Grocery store stocks extend post-CPI gains https://seekingalpha.com/news/3251760-grocery-store-stocks-extend-post-cpi-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3251760-grocery-store-stocks-extend-post-cpi-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251759\" data-ts=\"1489687426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251759-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SXC' title='SunCoke Energy'>SXC</a> <font color='green'>+9%</font>. SPP <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SXCP' title='SunCoke Energy Partners'>SXCP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/AXAS' title='Abraxas Petroleum Corporation'>AXAS</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CELP' title='Cypress Energy Partners, L.P.'>CELP</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/ECT' title='ECA Marcellus Trust I'>ECT</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251759\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$SXC $SNMP $PACD - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3251759-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3251759-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251873\" data-ts=\"1489686948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PACD\" target=\"_blank\">PACD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251873-pacific-drillingplus-6-proposals-suggest-3_2b-in-debt-converted-to-equity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Drilling +6% as proposals suggest $3.2B in debt converted to equity</a></h4><ul>     <li>Pacific Drilling (<a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='green'>+6.1%</font>) flies higher after an update on negotiations</a> with its creditors suggests that <a href=\"https://seekingalpha.com/article/4055737-pacific-drilling-might-see-current-equity-survive\" target=\"_blank\">some of its current equity could survive</a>.</li>     <li>After turning down a proposal that would leave shareholders with a 33% stake in a reorganized company, creditors propose converting all PACD debt into a 98% equity stake but also providing existing shareholders with warrants that could give them another 20% of the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251873\" data-linked=\"Pacific Drilling +6% as proposals suggest $3.2B in debt converted to equity\" data-tweet=\"$PACD - Pacific Drilling +6% as proposals suggest $3.2B in debt converted to equity https://seekingalpha.com/news/3251873-pacific-drillingplus-6-proposals-suggest-3_2b-in-debt-converted-to-equity?source=tweet\" data-url=\"https://seekingalpha.com/news/3251873-pacific-drillingplus-6-proposals-suggest-3_2b-in-debt-converted-to-equity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251749\" data-ts=\"1489684412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXTI\" target=\"_blank\">AXTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251749-axtminus-15_2-fire-beijing-facility-impacts-manufacturing-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AXT -15.2%, fire at Beijing facility impacts manufacturing production</a></h4><ul><li>AXT (NASDAQ:<a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a>) <a href=\"https://seekingalpha.com/pr/16773031-axt-inc-announces-fire-damage-manufacturing-production-area\" target=\"_blank\">reports</a> an electrical short-circuit fire at a production area for&nbsp;gallium arsenide and germanium crystal growth&nbsp;at the company's Beijing plant, leading to suspension of all wafer substrate processing.</li><li>Though no injuries or structural damage were realized, the production halt has AXT recalculating&nbsp;Q1 2017 revenue guidance to $18M-$18.5M, compared to $19.5M-$20.5M anticipated prior.</li><li>Considering the event a near-term concern and longer-term growth prospects intact, Needham &amp; Company <a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Reiterates+Buy+Rating+and+%248.50+PT+on+AXT%2C+Inc.+%28AXTI%29%3B+Fire+at+Beijing+Facility+Impacts+1Q17%2C+Not+Growth+Ahead/12675703.html\" target=\"_blank\">analyst Edwin Mok</a> reissues shares at Buy with an $8.50 target (current price $6.30).</li></ul><div class=\"tiny-share-widget\" data-id=\"3251749\" data-linked=\"AXT -15.2%, fire at Beijing facility impacts manufacturing production\" data-tweet=\"$AXTI - AXT -15.2%, fire at Beijing facility impacts manufacturing production https://seekingalpha.com/news/3251749-axtminus-15_2-fire-beijing-facility-impacts-manufacturing-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3251749-axtminus-15_2-fire-beijing-facility-impacts-manufacturing-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251753\" data-ts=\"1489684309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UTHR\" target=\"_blank\">UTHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251753-credit-suisse-negative-on-united-therapeutics-shares-slip-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse negative on United Therapeutics; shares slip 4%</a></h4><ul><li>United Therapeutics (<a href='https://seekingalpha.com/symbol/UTHR' title='United Therapeutics Corporation'>UTHR</a> <font color='red'>-4.4%</font>) goes south on modestly higher volume on the heels of an Underperform rating and $120 (14% downside risk)&nbsp;price target by Credit Suisse.</li><li>Analyst Alethia Young cites valuation and potential negative catalysts including a potential invalidity decision on its '393 patent (being challenged by SteadyMed) and a delay of RemoSynch approval due to the possible delay in the approval of the Medtronic device that will be used in the product.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3251753\" data-linked=\"Credit Suisse negative on United Therapeutics; shares slip 4%\" data-tweet=\"$UTHR - Credit Suisse negative on United Therapeutics; shares slip 4% https://seekingalpha.com/news/3251753-credit-suisse-negative-on-united-therapeutics-shares-slip-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3251753-credit-suisse-negative-on-united-therapeutics-shares-slip-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251751\" data-ts=\"1489684030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATI\" target=\"_blank\">ATI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251751-allegheny-tech-upgraded-to-buy-seaport-selloff-overdone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegheny Tech upgraded to Buy at Seaport as selloff overdone</a></h4><ul><li>Allegheny Tech (<a href='https://seekingalpha.com/symbol/ATI' title='Allegheny Technologies Incorporated'>ATI</a> <font color='green'>+3.3%</font>) is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/03/16/aerospace-business-should-take-allegheny-technologies-higher/\" target=\"_blank\">upgraded to Buy</a> from Neutral with a $22 price target at Seaport Global, which says the stock's selloff since an initial big bump that followed better than expected <a href=\"https://seekingalpha.com/news/3236926-allegheny-technologies-beats-0_07-misses-revenue\" target=\"_blank\">Q4 results</a> is overdone.</li><li>Seaport says ATI long has been strongly correlated to the price of nickel, but in the past two years the company has meaningfully reduced the size of its flat rolled segment; the firm thinks the aerospace-dominated high performance segment will be the key driver of future earnings growth, decoupling the stock from nickel prices.</li><li>The firm also sees potential upside for the stock given that guidance assumes only 42 of Boeing&rsquo;s 737 aircraft are produced per month, while Boeing has already said it will go to 47.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251751\" data-linked=\"Allegheny Tech upgraded to Buy at Seaport as selloff overdone\" data-tweet=\"$ATI - Allegheny Tech upgraded to Buy at Seaport as selloff overdone https://seekingalpha.com/news/3251751-allegheny-tech-upgraded-to-buy-seaport-selloff-overdone?source=tweet\" data-url=\"https://seekingalpha.com/news/3251751-allegheny-tech-upgraded-to-buy-seaport-selloff-overdone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251746\" data-ts=\"1489683235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251746-wynnplus-3-on-takeover-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wynn +3% on takeover chatter</a></h4><ul><li>Down earlier in the session, Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='green'>+2.9%</font>) has spiked higher amid some Twitter chatter about a $120-$125 per share offer from Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color='green'>+0.6%</font>).</li><li><strong>UPDATE</strong>: Shares of Wynn have peeled back after the company says there is no truth to the M&amp;A speculation making the rounds. WYNN&nbsp;<font color='green'>+1.77%.</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3251746\" data-linked=\"Wynn +3% on takeover chatter\" data-tweet=\"$WYNN $WYNN $LVS - Wynn +3% on takeover chatter https://seekingalpha.com/news/3251746-wynnplus-3-on-takeover-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3251746-wynnplus-3-on-takeover-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251744\" data-ts=\"1489682992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251744-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TOPS' title='TOP Ships Inc.'>TOPS</a> <font color='green'>+117%</font>. <a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='green'>+67%</font>. <a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics'>MCRB</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ADPT' title='Adeptus Health'>ADPT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/DAC' title='Danaos Corporation'>DAC</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/CDNA' title='CareDx'>CDNA</a> <font color='red'>-21%</font>. WAC <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/ARTX' title='Arotech Corporation'>ARTX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/VLTC' title='Voltari Corporation'>OTC:VLTC</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/PTHN' title='Patheon'>PTHN</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='red'>-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251744\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$TOPS $GLBS $INNL - Midday Gainers / Losers https://seekingalpha.com/news/3251744-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3251744-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251742\" data-ts=\"1489681949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROSG-OLD\" target=\"_blank\">ROSG-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251742-rosetta-genomics-shareholders-ok-12-fold-reduction-in-number-shares-post-split-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosetta Genomics shareholders OK 12-fold reduction in number shares; post-split trading commences tomorrow; shares ease 7%</a></h4><ul><li>Rosetta Genomics (<a href='https://seekingalpha.com/symbol/ROSG-OLD' title='Rosetta Genomics Ltd.'>ROSG-OLD</a> <font color='red'>-6.6%</font>) shareholders have <a href=\"https://seekingalpha.com/pr/16773673-rosetta-genomics-announces-1minus-12-reverse-stock-split\" target=\"_blank\">blessed </a>its proposed 1:12 reverse split of its common stock. Post-split trading starts tomorrow.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250718-rosetta-genomics-reverse-split-shares-1-12\" target=\"_blank\">Rosetta Genomics to reverse split shares 1:12</a> (March 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3251742\" data-linked=\"Rosetta Genomics shareholders OK 12-fold reduction in number shares; post-split trading commences tomorrow; shares ease 7%\" data-tweet=\"$ROSG-OLD - Rosetta Genomics shareholders OK 12-fold reduction in number shares; post-split trading commences tomorrow; shares ease 7% https://seekingalpha.com/news/3251742-rosetta-genomics-shareholders-ok-12-fold-reduction-in-number-shares-post-split-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/3251742-rosetta-genomics-shareholders-ok-12-fold-reduction-in-number-shares-post-split-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251741\" data-ts=\"1489681501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251741-consumers-top-5-gainers-losers-of-12-25\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumers - Top 5 Gainers / Losers as of 12:25</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/THST' title='Truett-Hurst, Inc.'>THST</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries Inc.'>OXM</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BGS' title='B&G Foods, Inc.'>BGS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/PRMW' title='Primo Water'>PRMW</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251741\" data-linked=\"Consumers - Top 5 Gainers / Losers as of 12:25\" data-tweet=\"$GPRO $OTIV $THST - Consumers - Top 5 Gainers / Losers as of 12:25 https://seekingalpha.com/news/3251741-consumers-top-5-gainers-losers-of-12-25?source=tweet\" data-url=\"https://seekingalpha.com/news/3251741-consumers-top-5-gainers-losers-of-12-25\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251736\" data-ts=\"1489680074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAC\" target=\"_blank\">DAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251736-shipping-stocks-break-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shipping stocks break higher</a></h4><ul> <li>Some shipping stocks are notably higher as various shipping rates continue to improve.</li> <li>Shares of Danaos Corporation (NYSE:<a href='https://seekingalpha.com/symbol/DAC' title='Danaos Corporation'>DAC</a>) shoot <font color='green'>up 12%</font> to $1.85 on strong volume. The 52-week range on Danaos is $1.60 to $4.90.</li> <li>Euroseas (NASDAQ:<a href='https://seekingalpha.com/symbol/ESEA' title='Euroseas Ltd.'>ESEA</a>) is <font color='green'>13% higher</font> to $1.16 vs. a 52-week trading range of $1.04 to $8.07.</li> <li>DryShips (NASDAQ:<a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a>) is <font color='green'>up 6%</font> to $1.81. The company has fired off several reverse stock splits making comparisons tricky..</li> <li>Star Bulk Carriers (NASDAQ:<a href='https://seekingalpha.com/symbol/SBLK' title='Star Bulk Carriers Corp.'>SBLK</a>) <font color='green'>jumps 7%</font> to hit $10.82 vs. a 52-week trading range of $2.61 to $11.14.</li> <li>Costamare (NYSE:<a href='https://seekingalpha.com/symbol/CMRE' title='Costamare Inc.'>CMRE</a>) <font color='green'>gains 5%</font> to $6.79 vs. a 52-week trading range of $5.07 to $11.00.</li> <li>Other movers include Scorpio Bulkers (<a href='https://seekingalpha.com/symbol/SB' title='Safe Bulkers Inc.'>SB</a> <font color='green'>+0.6%</font>), Seaenergy Maritime Holdings (<a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a> <font color='green'>+9.8%</font>), Diana Shipping (<a href='https://seekingalpha.com/symbol/DSX' title='Diana Shipping, Inc.'>DSX</a> <font color='green'>+3%</font>) and Globus Maritime (<a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='green'>+61.9%</font>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3251736\" data-linked=\"Shipping stocks break higher\" data-tweet=\"$DAC $DAC $ESEA - Shipping stocks break higher https://seekingalpha.com/news/3251736-shipping-stocks-break-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3251736-shipping-stocks-break-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251735\" data-ts=\"1489679320\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INNL\" target=\"_blank\">INNL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251735-trading-suspended-in-innocoll-pending-news-shares-up-35\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading suspended in Innocoll pending news; shares up 35%</a></h4><ul><li>Nasdaq has halted traded in Innocoll Holdings (<a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='green'>+35.1%</font>) pending the release of news.</li><li>Shares plummeted in December after the FDA rejected its marketing application for postsurgical pain med XARACOLL.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251735\" data-linked=\"Trading suspended in Innocoll pending news; shares up 35%\" data-tweet=\"$INNL - Trading suspended in Innocoll pending news; shares up 35% https://seekingalpha.com/news/3251735-trading-suspended-in-innocoll-pending-news-shares-up-35?source=tweet\" data-url=\"https://seekingalpha.com/news/3251735-trading-suspended-in-innocoll-pending-news-shares-up-35\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251734\" data-ts=\"1489679231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRMW\" target=\"_blank\">PRMW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251734-primo-water-lower-after-posting-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Primo Water lower after posting Q4 results</a></h4><ul> <li>Primo Water (<a href='https://seekingalpha.com/symbol/PRMW' title='Primo Water'>PRMW</a> <font color='red'>-6.3%</font>) trades lower after <a href=\"https://seekingalpha.com/pr/16772594-primo-water-announces-fourth-quarter-full-year-2016-financial-results-exceeding-guidance\" target=\"_blank\">Q4</a> EPS falls short of the consensus estimate, even as EBITDA topped the company's guidance.</li> <li>Gross margin fell 40 bpds to 28.6% of sales as a shift in sales mix factored in.</li> <li>Looking ahead, Primo expects 2017 revenue of $280M to $285M and EBITDA of $52M to $54M.</li> <li>Shares of Primo peaked at a 52-week high of $15.39 in February.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3251456-primo-water-misses-0_05-beats-revenue\" target=\"_blank\">Primo Water misses by $0.05, beats on revenue</a> (March 15)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251734\" data-linked=\"Primo Water lower after posting Q4 results\" data-tweet=\"$PRMW - Primo Water lower after posting Q4 results https://seekingalpha.com/news/3251734-primo-water-lower-after-posting-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3251734-primo-water-lower-after-posting-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251733\" data-ts=\"1489678509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITE\" target=\"_blank\">LITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251733-lumentum-upgraded-to-neutral-goldman-sachs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lumentum upgraded to Neutral at Goldman Sachs</a></h4><ul><li>Positive on 3D sensing prospects given likely incorporation of the technology among upcoming flagship smartphone models, <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Lumentum+%28LITE%29+to+Neutral/12674130.html\" target=\"_blank\">analyst Doug Clark</a> raises from Conviction Sell. Target from $38 to $45.</li><li>Lumentum (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>)&nbsp;$48.30,&nbsp;<font color='green'>+5.81%</font>.</li><li>Earlier (March 16, 2017):&nbsp;<a href=\"https://seekingalpha.com/news/3251636-infinera-upgraded-buy-goldman-sachs-plus-3_96-percent\" target=\"_blank\">Infinera upgraded to Buy at Goldman Sachs; +3.96%</a>&nbsp;/&nbsp;<a href=\"https://seekingalpha.com/news/3251648-goldman-sachs-reduces-ciena-neutral\" target=\"_blank\">Goldman Sachs reduces Ciena to Neutral</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251733\" data-linked=\"Lumentum upgraded to Neutral at Goldman Sachs\" data-tweet=\"$LITE - Lumentum upgraded to Neutral at Goldman Sachs https://seekingalpha.com/news/3251733-lumentum-upgraded-to-neutral-goldman-sachs?source=tweet\" data-url=\"https://seekingalpha.com/news/3251733-lumentum-upgraded-to-neutral-goldman-sachs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251730\" data-ts=\"1489677647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251730-healthcare-top-5-gainers-losers-of-11-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:20</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics'>MCRB</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/ADPT' title='Adeptus Health'>ADPT</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/PTHN' title='Patheon'>PTHN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251730\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:20\" data-tweet=\"$INNL $MCRB $ADPT-RETIRED - Healthcare - Top 5 Gainers / Losers as of 11:20 https://seekingalpha.com/news/3251730-healthcare-top-5-gainers-losers-of-11-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3251730-healthcare-top-5-gainers-losers-of-11-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251728\" data-ts=\"1489677484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TELL\" target=\"_blank\">TELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251728-tellurianminus-10-on-plans-to-sell-200m-in-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tellurian -10% on plans to sell $200M in stock</a></h4><ul><li>Tellurian (<a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-10.3%</font>) plunges ~10% after <a href=\"https://seekingalpha.com/filing/3462106\" target=\"_blank\">filing to sell</a>  common stock for up to $200M in sales proceeds.</li><li>Just <a href=\"https://www.sec.gov/Archives/edgar/data/61398/000119312517038543/d344466ds3asr.htm\" target=\"_blank\">last month</a>, TELL filed for a mixed securities shelf offering as well as a potential offering of ~500K common shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251728\" data-linked=\"Tellurian -10% on plans to sell $200M in stock\" data-tweet=\"$TELL - Tellurian -10% on plans to sell $200M in stock https://seekingalpha.com/news/3251728-tellurianminus-10-on-plans-to-sell-200m-in-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3251728-tellurianminus-10-on-plans-to-sell-200m-in-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251724\" data-ts=\"1489676216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOL\" target=\"_blank\">TOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251724-homebuilders-outperform-housing-starts-top-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Homebuilders outperform as housing starts top expectations</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3251643-housing-starts-top-estimates-february\" target=\"_blank\">February housing starts</a> rose 3% from January to a seasonally adjusted annualized rate of 1.288M. Estimates were for 1.26M. While permits dipped 6% in February, they're still higher by more than 4% Y/Y.</li><li>Of note, however, was an unusually warm February, and one wonders what gains last month may be taken away by what's become a pretty harsh March.</li><li>The major averages are flat on the session, but the <a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a> is&nbsp;<font color='green'>higher by 1.4%</font>, and <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a>&nbsp;<font color='green'>0.8%</font>.</li><li>Toll Brothers (<a href='https://seekingalpha.com/symbol/TOL' title='Toll Brothers Inc.'>TOL</a> <font color='green'>+1.7%</font>), KB Home (<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a> <font color='green'>+1.8%</font>), Pulte (<a href='https://seekingalpha.com/symbol/PHM' title='PulteGroup, Inc.'>PHM</a> <font color='green'>+1.3%</font>), D.R. Horton (<a href='https://seekingalpha.com/symbol/DHI' title='D. R. Horton Inc.'>DHI</a> <font color='green'>+1.2%</font>), Lennar (<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color='green'>+1.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3251724\" data-linked=\"Homebuilders outperform as housing starts top expectations\" data-tweet=\"$TOL $ITB $XHB - Homebuilders outperform as housing starts top expectations https://seekingalpha.com/news/3251724-homebuilders-outperform-housing-starts-top-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3251724-homebuilders-outperform-housing-starts-top-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251715\" data-ts=\"1489674734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251715-natural-gas-futures-go-south-on-less-expected-inventory-draw\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas futures go south on less than expected inventory draw</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a>&nbsp;<strong>-53</strong> Bcf vs. -56 Bcf consensus, -68 Bcf last week. Futures <font color='red'>-2.8%</font>&nbsp;to $2.898.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251715\" data-linked=\"Natural gas futures go south on less than expected inventory draw\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas futures go south on less than expected inventory draw https://seekingalpha.com/news/3251715-natural-gas-futures-go-south-on-less-expected-inventory-draw?source=tweet\" data-url=\"https://seekingalpha.com/news/3251715-natural-gas-futures-go-south-on-less-expected-inventory-draw\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251703\" data-ts=\"1489673479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251703-trumps-proposed-2018-budget-trims-nih-funding-20-healthcare-stocks-in-red\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump&#39;s proposed 2018 budget trims NIH funding 20%; healthcare stocks in the red</a></h4><ul><li>Healthcare stocks are under pressure in early trading on the heels of the Trump administration's release of its <a href=\"https://www.theatlantic.com/politics/archive/2017/03/trumps-budget-cuts-nih-funding-by-20-percent/519771/\" target=\"_blank\">proposed 2018 budget</a> that includes a 20% haircut for the National Institutes of Health &#40;NIH&#41; to $5.8B. Observers and legislators were expecting an increase of $1B - 2B.</li><li>The White House's budget also includes a major reorganization of NIH's institutes and centers to \"help focus resources on the highest priority research and training activities.\"</li><li>NIH funds ~300K scientists worldwide.</li><li>ETFs: (<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/BIS' title='ProShares UltraShort Nasdaq Biotechnology ETF'>BIS</a> <font color='green'>+1.6%</font>)(<a href='https://seekingalpha.com/symbol/CNCR' title='Loncar Cancer Immunotherapy ETF'>CNCR</a> <font color='green'>+0.5%</font>)(<a href='https://seekingalpha.com/symbol/ARKG' title='ARK Genomic Revolution Multi-Sector ETF'>ARKG</a> <font color='red'>-0.4%</font>)(<a href='https://seekingalpha.com/symbol/PJP' title='Invesco Dynamic Pharmaceuticals Portfolio ETF'>PJP</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/IHE' title='iShares U.S. Pharmaceuticals ETF'>IHE</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/XPH' title='SPDR S&P Pharmaceuticals ETF'>XPH</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/PPH' title='VanEck Vectors Pharmaceutical ETF'>PPH</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/IHI' title='iShares U.S. Medical Devices ETF'>IHI</a> <font color='red'>-0.8%</font>)(<a href='https://seekingalpha.com/symbol/XHE' title='SPDR S&P Health Care Equipment ETF'>XHE</a> <font color='red'>-0.4%</font>)</li><li>Cross-section of tickers: (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='red'>-0.5%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='red'>-4.1%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a> <font color='red'>-3.7%</font>)(<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a> <font color='red'>-0.8%</font>)(<a href='https://seekingalpha.com/symbol/BSX' title='Boston Scientific Corporation'>BSX</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a> <font color='red'>-0.8%</font>)(<a href='https://seekingalpha.com/symbol/TMO' title='Thermo Fisher Scientific Inc.'>TMO</a> <font color='red'>-2.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3251703\" data-linked=\"Trump&#39;s proposed 2018 budget trims NIH funding 20%; healthcare stocks in the red\" data-tweet=\"$MRK $IBB $BIB - Trump&#39;s proposed 2018 budget trims NIH funding 20%; healthcare stocks in the red https://seekingalpha.com/news/3251703-trumps-proposed-2018-budget-trims-nih-funding-20-healthcare-stocks-in-red?source=tweet\" data-url=\"https://seekingalpha.com/news/3251703-trumps-proposed-2018-budget-trims-nih-funding-20-healthcare-stocks-in-red\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>286&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251698\" data-ts=\"1489672891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMNB\" target=\"_blank\">FMNB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251698-farmers-national-bancorp-to-buy-monitor-bancorp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Farmers National Bancorp to buy Monitor Bancorp</a></h4><ul><li>Based on the current estimate for tangible book value at Monitor, <a href=\"https://seekingalpha.com/pr/16769021-farmers-national-banc-corp-acquire-monitor-bancorp-inc\" target=\"_blank\">the cash and stock deal</a> would be valued at about $7.8M.</li><li><a href='https://seekingalpha.com/symbol/FMNB' title='Farmers National Banc Corp.'>FMNB</a><font color='green'> +0.35%</font>&nbsp;in early action today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251698\" data-linked=\"Farmers National Bancorp to buy Monitor Bancorp\" data-tweet=\"$FMNB - Farmers National Bancorp to buy Monitor Bancorp https://seekingalpha.com/news/3251698-farmers-national-bancorp-to-buy-monitor-bancorp?source=tweet\" data-url=\"https://seekingalpha.com/news/3251698-farmers-national-bancorp-to-buy-monitor-bancorp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251696\" data-ts=\"1489672838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251696-ibm-raised-to-212-target-morgan-stanley-cloud-cited-undervalued\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM raised to $212 target at Morgan Stanley, cloud cited undervalued</a></h4><ul><li><a href=\"http://blogs.barrons.com/techtraderdaily/2017/03/15/ibm-undervalued-compared-to-all-other-cloud-companies-says-morgan-stanley/\" target=\"_blank\">Noting</a> public cloud units at Amazon and Microsoft are generally modeled, and valued, in line with characteristic adoption cycle (base case), firm suggests IBM (<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a> <font color='green'>+1.2%</font>) exists external of similar classification.</li><li>Expects IBM's public cloud operation to expand at a 33% 2016-2020 CAGR, with gross and operating margins to trend in line with average industry figures by 2020, though notes calculations as prospectively conservative.</li><li>Price target from $187 (current price $177.90).</li></ul><div class=\"tiny-share-widget\" data-id=\"3251696\" data-linked=\"IBM raised to $212 target at Morgan Stanley, cloud cited undervalued\" data-tweet=\"$IBM - IBM raised to $212 target at Morgan Stanley, cloud cited undervalued https://seekingalpha.com/news/3251696-ibm-raised-to-212-target-morgan-stanley-cloud-cited-undervalued?source=tweet\" data-url=\"https://seekingalpha.com/news/3251696-ibm-raised-to-212-target-morgan-stanley-cloud-cited-undervalued\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251693\" data-ts=\"1489672415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNVA\" target=\"_blank\">RNVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251693-rennova-inks-discounted-convertible-debt-deal-institutional-investors-shares-slip-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rennova inks discounted convertible debt deal with institutional investors; shares slip 8%</a></h4><ul><li>Nano cap Rennova Health (<a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='red'>-7.7%</font>) eases on a 50% spike on volume in response to its <a href=\"https://seekingalpha.com/filing/3462695\" target=\"_blank\">agreement</a> with institutional investors that will allow them to exchange their holdings for new debentures at a 24% discount.</li><li>Under the terms of the Securities Purchase Agreement, the company will issue $10.85M of two-year Senior Secured Original Issue Discount Convertible Debentures and three series of warrants to purchase common shares. Gross proceeds should be $8.75M. Closing date is March 20.</li><li>In the simultaneous Exchange Agreement, the holder of its Original Issue Discount Convertible Debentures issued on February 2, 2017 will be able to exchange the debt for the new issue as will the holder of its Series H Convertible Preferred Stock. All issuance amounts reflect the above discount.</li><li>The debentures can be converted at any time for $1.66 per common share.</li><li>Yesterday's close was $1.96.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251693\" data-linked=\"Rennova inks discounted convertible debt deal with institutional investors; shares slip 8%\" data-tweet=\"$RNVA - Rennova inks discounted convertible debt deal with institutional investors; shares slip 8% https://seekingalpha.com/news/3251693-rennova-inks-discounted-convertible-debt-deal-institutional-investors-shares-slip-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3251693-rennova-inks-discounted-convertible-debt-deal-institutional-investors-shares-slip-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251692\" data-ts=\"1489672174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEIM\" target=\"_blank\">FEIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251692-frequency-electronics-reports-fq3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frequency Electronics reports FQ3 results</a></h4><ul><li>Frequency Electronics (NASDAQ:<a href='https://seekingalpha.com/symbol/FEIM' title='Frequency Electronics, Inc.'>FEIM</a>): FQ3 EPS of $0.04</li><li>Revenue of $12.8M (-5.2% Y/Y)</li><li>Shares <font color='green'>+4.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16773457-frequency-electronics-inc-announces-third-quarter-fiscal-year-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251692\" data-linked=\"Frequency Electronics reports FQ3 results\" data-tweet=\"$FEIM - Frequency Electronics reports FQ3 results https://seekingalpha.com/news/3251692-frequency-electronics-reports-fq3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3251692-frequency-electronics-reports-fq3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251685\" data-ts=\"1489671743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BEN\" target=\"_blank\">BEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251685-ben-boosted-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BEN boosted by upgrade</a></h4><ul><li>This just in: Amid a near-constant stream of bad news for traditional asset managers, Franklin Resources (NYSE:<a href='https://seekingalpha.com/symbol/BEN' title='Franklin Resources Inc.'>BEN</a>) is&nbsp;<font color='green'>higher by nearly 50%</font>&nbsp;since its 2016 low hit right around July 4.</li><li>BAML analyst Michael Carrier climbs on board, upgrading to Buy from Neutral. His $50 price target suggests another&nbsp;<font color='green'>16% upside</font>&nbsp;from yesterday's close.</li><li>Carrier expects better organic growth thanks to improving relative performance at the company's major funds.</li><li>There's also the potential for cash repatriation (and associated buybacks/boosted dividends), a \"less burdensome\" fiduciary rule, and an emphasis on cost controls.</li><li>Shares&nbsp;<font color='green'>+2.7%</font>&nbsp;today to $44.17.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251685\" data-linked=\"BEN boosted by upgrade\" data-tweet=\"$BEN - BEN boosted by upgrade https://seekingalpha.com/news/3251685-ben-boosted-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3251685-ben-boosted-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251683\" data-ts=\"1489671408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251683-tyson-foods-slips-after-argus-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson Foods slips after Argus downgrade</a></h4><ul> <li>Argus <a href=\"https://www.marketbeat.com/stocks/NYSE/TSN/\" target=\"_blank\">downgrades</a> Tyson Foods (NYSE:<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a>) to a Hold rating after having the consumer goods stock set at Buy.</li> <li>Tyson has opened trading <font color='red'>down 1.58%</font>. Shares of Tyson have swung back and forth in a tight $62 to $65 range for most of the last ten weeks.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3251683\" data-linked=\"Tyson Foods slips after Argus downgrade\" data-tweet=\"$TSN - Tyson Foods slips after Argus downgrade https://seekingalpha.com/news/3251683-tyson-foods-slips-after-argus-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3251683-tyson-foods-slips-after-argus-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251677\" data-ts=\"1489670715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251677-trovagene-laying-almost-60-of-workforce-shares-slip-17-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trovagene laying almost 60% of workforce; shares slip 17% premarket</a></h4><ul><li>Liquid biopsy firm Trovagene (NASDAQ:<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>) slumps&nbsp;<font color='red'>17%</font>&nbsp;premarket on management's <a href=\"https://seekingalpha.com/article/4055639-trovagenes-trov-ceo-bill-welch-q4-2016-results-earnings-call-transcript?page=5\" target=\"_blank\">disclosure </a>that it will lay off 30 of its 53 employees as part of its restructuring related to its \"expansion\" into cancer therapeutics. The company expects to save ~$8M in annual expenses from the action.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3251476-trovagene-nabs-rights-leukemia-candidate-nerviano-medical\" target=\"_blank\">Trovagene nabs rights to leukemia candidate from Nerviano Medical</a> (March 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3251677\" data-linked=\"Trovagene laying almost 60% of workforce; shares slip 17% premarket\" data-tweet=\"$TROV - Trovagene laying almost 60% of workforce; shares slip 17% premarket https://seekingalpha.com/news/3251677-trovagene-laying-almost-60-of-workforce-shares-slip-17-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3251677-trovagene-laying-almost-60-of-workforce-shares-slip-17-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251675\" data-ts=\"1489670409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251675-premarket-gainers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:10 am</a></h4><ul>     <li>SKLN <font color='green'>+13%</font> on Q4 earnings.</li>     <li><a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='green'>+12%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='green'>+11%</font> on increased guidance and restructuring for 2017.</li>     <li><a href='https://seekingalpha.com/symbol/JASO' title='JA Solar Holdings, Co., Ltd.'>JASO</a> <font color='green'>+10%</font> on Q4 earnings beat.</li>     <li><a href='https://seekingalpha.com/symbol/ALRM' title='Alarm.com'>ALRM</a> <font color='green'>+9%</font> on Q4 earnings beat.</li>     <li>CERU <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a> <font color='green'>+8%</font> on Q4 earnings beat.</li>     <li><a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='green'>+8%</font> on Q4 earnings.</li>     <li>ITEK <font color='green'>+7%</font> on FY earnings.</li>     <li><a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a> <font color='green'>+7%</font> on Q3 earnings beat and increased dividend.</li>     <li><a href='https://seekingalpha.com/symbol/KCG' title='KCG Holdings, Inc.'>KCG</a> <font color='green'>+6%</font> on non-binding proposal by Virtu.</li>     <li><a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+5% </font>on Q4 earnings.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251675\" data-linked=\"Premarket Gainers as of 9:10 am\" data-tweet=\"$POAI $OCRX $GPRO - Premarket Gainers as of 9:10 am https://seekingalpha.com/news/3251675-premarket-gainers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3251675-premarket-gainers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251670\" data-ts=\"1489670030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUE\" target=\"_blank\">NUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251670-nucorplus-3-premarket-after-guiding-q1-earnings-far-above-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nucor +3% premarket after guiding Q1 earnings far above consensus</a></h4><ul>     <li>Nucor (NYSE:<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>)&nbsp;<font color='green'>+3.3%</font> premarket after issuing <a href=\"https://seekingalpha.com/pr/16773353-nucor-announces-guidance-first-quarter-earnings\" target=\"_blank\">upside guidance for Q1 earnings</a>, seeing EPS of $1.10-$1.15 vs. $0.69 analyst consensus estimate; Q4 EPS came in at $0.50, and Q1 2016 EPS was $0.27.</li><li>NUE credits the expected improvement to higher profitability in its steel mills segment, and says it is encouraged by renewed growth in demand in the non-residential construction and energy markets.</li>     <li>NUE says it recently resumed operations in Louisiana after an unplanned outage that began in early February caused by an equipment failure; NUE says it also completed planned maintenance that was scheduled for later in the year.</li><li>On watch: <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a>, <a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>, <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3251670\" data-linked=\"Nucor +3% premarket after guiding Q1 earnings far above consensus\" data-tweet=\"$NUE $NUE $X - Nucor +3% premarket after guiding Q1 earnings far above consensus https://seekingalpha.com/news/3251670-nucorplus-3-premarket-after-guiding-q1-earnings-far-above-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3251670-nucorplus-3-premarket-after-guiding-q1-earnings-far-above-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251668\" data-ts=\"1489669815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GKOS\" target=\"_blank\">GKOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251668-u-s-reimbursement-codes-covering-glaukos-istent-extended-for-five-years-shares-ahead-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S reimbursement codes covering Glaukos&#39; iStent extended for five years; shares ahead 6% premarket</a></h4><ul><li>Glaukos (NYSE:<a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket, albeit on only 859 shares, in response to its <a href=\"https://seekingalpha.com/pr/16772947-glaukos-announces-five-year-extensions-three-category-iii-cpt-codes-related-micro-invasive\" target=\"_blank\">announcement </a>that the CPT codes used by physicians for reimbursement for implanting the <em>iStent </em>device have been extended five years.</li><li>CEO Thomas Burns says, &ldquo;The AMA CPT Editorial Panel&rsquo;s decision to grant these extensions is important to the continued surgeon adoption of&nbsp;<i>iStent&nbsp;</i>and MIGS, a new technology class we pioneered to provide glaucoma patients a viable potential alternative to daily, multi-dose prescription eye drops or complex surgeries. As we pursue FDA approval of our next-generation&nbsp;<i>iStent&nbsp;</i>technologies, we are pleased to have the corresponding CPT codes already in place and will use this time to continue to build upon the growing body of published research that documents their clinical performance.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3251668\" data-linked=\"U.S reimbursement codes covering Glaukos&#39; iStent extended for five years; shares ahead 6% premarket\" data-tweet=\"$GKOS - U.S reimbursement codes covering Glaukos&#39; iStent extended for five years; shares ahead 6% premarket https://seekingalpha.com/news/3251668-u-s-reimbursement-codes-covering-glaukos-istent-extended-for-five-years-shares-ahead-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3251668-u-s-reimbursement-codes-covering-glaukos-istent-extended-for-five-years-shares-ahead-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251666\" data-ts=\"1489669374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSN\" target=\"_blank\">CLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251666-celsion-eps-and-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celsion EPS and revenue in-line</a></h4><ul><li>Celsion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a>): FY EPS of -$0.85 in-line.</li><li>Revenue of $0.5M in-line (flat Y/Y).</li><li>Shares <font color='green'>+11.7%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16773372-celsion-corporation-reports-year-end-2016-financial-results-provides-business-update'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251666\" data-linked=\"Celsion EPS and revenue in-line\" data-tweet=\"$CLSN - Celsion EPS and revenue in-line https://seekingalpha.com/news/3251666-celsion-eps-and-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3251666-celsion-eps-and-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251665\" data-ts=\"1489669369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNOA\" target=\"_blank\">SNOA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251665-small-dermatitis-study-of-sonoma-pharmas-sebuderm-shows-treatment-effect-shares-ahead-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Small dermatitis study of Sonoma Pharma&#39;s SebuDerm shows treatment effect; shares ahead 3% premarket</a></h4><ul><li>Thinly traded nano cap Sonoma Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNOA' title='Sonoma Pharmaceuticals, Inc.'>SNOA</a>) perks up&nbsp;<font color='green'>3%&nbsp;</font>premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16772849-sonoma-pharmaceuticals-announces-results-sebuderm-gel-study-treatment-seborrheic-dermatitis\" target=\"_blank\">announcement </a>of positive results from a 25-subject study evaluating SebuDerm (topical hypochlorous acid) gel for the treatment of mild-to-moderate facial and scalp seborrheic dermatitis. The data will be presented at the 13th Annual Maui Dermatology Conference in Hawaii, March 20 - 24.</li><li>Treated patients showed a 33% improvement from baseline at day 14 and 52% improvement at day 28 as measured by investigator's global assessment &#40;IGA&#41;. The improvement from baseline at 28 was 62% as measured by subject global assessment &#40;SGA&#41;.</li><li>U.S. commercialization is underway via the company's direct salesforce. Distribution partners are being recruited ex-U.S.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251665\" data-linked=\"Small dermatitis study of Sonoma Pharma&#39;s SebuDerm shows treatment effect; shares ahead 3% premarket\" data-tweet=\"$SNOA - Small dermatitis study of Sonoma Pharma&#39;s SebuDerm shows treatment effect; shares ahead 3% premarket https://seekingalpha.com/news/3251665-small-dermatitis-study-of-sonoma-pharmas-sebuderm-shows-treatment-effect-shares-ahead-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3251665-small-dermatitis-study-of-sonoma-pharmas-sebuderm-shows-treatment-effect-shares-ahead-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251662\" data-ts=\"1489669179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251662-post-fed-gold-rally-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-Fed gold rally continues</a></h4><ul><li>Gold traders continue to \"buy the news\" after selling the rumor of a Fed rate hike for the previous two weeks.</li><li>Advancing further this morning, gold is now up to $1,232 per ounce vs. $1,200 prior to the Fed rate hike yesterday afternoon.</li><li><a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a><font color='green'> +0.85%</font>&nbsp;premarket; the gold miners ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>)&nbsp;<font color='green'>+1.2%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3251380-stocks-bonds-gold-turn-higher-rate-hike-dollar-moves-south\" target=\"_blank\">Stocks, bonds, gold turn higher after rate hike; dollar moves south</a> (March 15)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='ETFS Physical Swiss Gold Trust ETF'>SGOL</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/DGL' title='PowerShares DB Gold ETF'>DGL</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/GYEN' title='AdvisorShares Gartman Gold/Yen ETF'>GYEN</a>, <a href='https://seekingalpha.com/symbol/GEUR' title='AdvisorShares Gartman Gold/Euro ETF'>GEUR</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/QGLDX' title='The Gold Bullion Strategy Fund Inv'>QGLDX</a>, <a href='https://seekingalpha.com/symbol/GHE' title='REX Gold Hedged FTSE Emerging Markets ETF'>GHE</a>, <a href='https://seekingalpha.com/symbol/GHS' title='REX Gold Hedged S&P 500 ETF'>GHS</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251662\" data-linked=\"Post-Fed gold rally continues\" data-tweet=\"$GLD $GDX $IAU - Post-Fed gold rally continues https://seekingalpha.com/news/3251662-post-fed-gold-rally-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3251662-post-fed-gold-rally-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251661\" data-ts=\"1489669164\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GES\" target=\"_blank\">GES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251661-guess-to-shrink-u-s-business-after-weak-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guess to shrink U.S. business after weak results</a></h4><ul> <li>Guess (NYSE:<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a>) falls in early trading after <a href=\"https://seekingalpha.com/pr/16772572-guess-inc-reports-fourth-quarter-results\" target=\"_blank\">Q4</a> numbers trailed estimates.</li> <li>The retailer's comparable sales dropped 7.8% during the quarter vs. +1.4% expected by analysts. The drop in sales pressured margins, with operating margin trailing off 270 bps to 7.9% of sales.</li> <li>The company says it has \"good\" momentum in Asia and Europe, but faces pressing problems in the U.S.</li> <li>Guess on the U.S. business: \"In the Americas Retail, where the retail environment remains challenging, we are focused on profitability improvements. We will continue to negotiate rent reductions whenever possible and plan to close 60 stores in fiscal 2018.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3251439-guess-misses-0_03-misses-revenue\" target=\"_blank\">Guess misses by $0.03, misses on revenue</a> (March 15)</li> <li>GES <font color='red'>-15.78%</font> premarket to $10.30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251661\" data-linked=\"Guess to shrink U.S. business after weak results\" data-tweet=\"$GES - Guess to shrink U.S. business after weak results https://seekingalpha.com/news/3251661-guess-to-shrink-u-s-business-after-weak-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3251661-guess-to-shrink-u-s-business-after-weak-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251655\" data-ts=\"1489668622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVRS\" target=\"_blank\">CVRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251655-corindus-closes-45m-private-capital-raise-shares-slip-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corindus closes $45M private capital raise; shares slip 10% premarket</a></h4><ul><li>Corindus Vascular Robotics (NYSEMKT:<a href='https://seekingalpha.com/symbol/CVRS' title='Corindus Vascular Robotics, Inc.'>CVRS</a>) <a href=\"https://seekingalpha.com/pr/16772919-corindus-vascular-robotics-announces-closing-private-placement-45-million\" target=\"_blank\">finalizes </a>its previously announced private placement of more that 65M shares of common stock at $0.6616. Net proceeds will be used for general corporate purposes.</li><li>Shares are off&nbsp;<font color='red'>10%</font>&nbsp;premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247010-corindus-vascular-secures-45m-capital-raise\" target=\"_blank\">Corindus Vascular secures $45M capital raise</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3251655\" data-linked=\"Corindus closes $45M private capital raise; shares slip 10% premarket\" data-tweet=\"$CVRS - Corindus closes $45M private capital raise; shares slip 10% premarket https://seekingalpha.com/news/3251655-corindus-closes-45m-private-capital-raise-shares-slip-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3251655-corindus-closes-45m-private-capital-raise-shares-slip-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251653\" data-ts=\"1489668320\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INNV\" target=\"_blank\">INNV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251653-innovus-pharma-prices-equity-offering-0_15-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Innovus Pharma prices equity offering at $0.15/share</a></h4><ul><li>Innovus Pharmaceuticals (<a href='https://seekingalpha.com/symbol/INNV' title='Innovus Pharmaceuticals, Inc.'>OTCQB:INNV</a>) <a href=\"https://seekingalpha.com/pr/16772873-innovus-pharmaceuticals-announces-3_85-million-public-offering\" target=\"_blank\">prices </a>its public offering of 25,666,669 shares of common stock at $0.15 per share. For each share purchased, investors will receive one one-year warrant to purchase one share of common at $0.15 and one five-year warrant to purchase one share of common at $0.15. Closing date is March 21.</li><li>Net proceeds of ~$3.3M will fund the commercial launch of FlutiCare, if approved by the FDA, working capital and general corporate purposes.</li><li>Yesterday's close was $0.1755.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251653\" data-linked=\"Innovus Pharma prices equity offering at $0.15/share\" data-tweet=\"$INNV - Innovus Pharma prices equity offering at $0.15/share https://seekingalpha.com/news/3251653-innovus-pharma-prices-equity-offering-0_15-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3251653-innovus-pharma-prices-equity-offering-0_15-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251648\" data-ts=\"1489667638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251648-goldman-sachs-reduces-ciena-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs reduces Ciena to Neutral</a></h4><ul><li>Though remaining positive on Ciena's (NASDAQ:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) exposure to customers, metro project wins, bettering web 2.0 traction, positioning among Tier-1 deployments and prospects in India, <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+CIENA+%28CIEN%29+to+Neutral/12674128.html\" target=\"_blank\">analyst Doug Clark</a> nevertheless lowers from Conviction Buy on tightening competition and limited margin upside.</li><li>Price target $27 ($23.35,&nbsp;<font color='red'>-1.64%</font>&nbsp;pre-market).</li></ul><div class=\"tiny-share-widget\" data-id=\"3251648\" data-linked=\"Goldman Sachs reduces Ciena to Neutral\" data-tweet=\"$CIEN - Goldman Sachs reduces Ciena to Neutral https://seekingalpha.com/news/3251648-goldman-sachs-reduces-ciena-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3251648-goldman-sachs-reduces-ciena-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251647\" data-ts=\"1489667620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXDC\" target=\"_blank\">CXDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251647-china-xd-plastics-reports-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China XD Plastics reports Q4 results</a></h4><ul><li>China XD Plastics (NASDAQ:<a href='https://seekingalpha.com/symbol/CXDC' title='China XD Plastics Company Limited'>CXDC</a>): Q4 EPS of $0.56</li><li>Revenue of $377.66M (+38.5% Y/Y)</li><li>Shares <font color='green'>+2%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16773197-specialty-chemical-company-china-xd-plastics-announces-fourth-quarter-fiscal-year-2016'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251647\" data-linked=\"China XD Plastics reports Q4 results\" data-tweet=\"$CXDC - China XD Plastics reports Q4 results https://seekingalpha.com/news/3251647-china-xd-plastics-reports-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3251647-china-xd-plastics-reports-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251639\" data-ts=\"1489667051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPI\" target=\"_blank\">IPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251639-intrepid-potashminus-12-after-pricing-43_5m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intrepid Potash -12% after pricing 43.5M share offering</a></h4><ul><li>Intrepid Potash (NYSE:<a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a>) <font color='red'>-11.9%</font> premarket after <a href=\"http://investors.intrepidpotash.com/phoenix.zhtml?c=218952&amp;p=irol-newsArticle&amp;ID=2254392&amp;highlight=\" target=\"_blank\">pricing</a> a ~43.54M-share <a href=\"https://seekingalpha.com/news/3251438-intrepid-potash-launch-public-stock-offering-size-disclosed\" target=\"_blank\">public offering</a> for gross proceeds of $52.3M, with an underwriters option to purchase up to an additional ~6.53M common shares.</li><li>IPI says the proceeds will be used  to partially repay indebtedness outstanding under its senior  notes and for general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251639\" data-linked=\"Intrepid Potash -12% after pricing 43.5M share offering\" data-tweet=\"$IPI - Intrepid Potash -12% after pricing 43.5M share offering https://seekingalpha.com/news/3251639-intrepid-potashminus-12-after-pricing-43_5m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3251639-intrepid-potashminus-12-after-pricing-43_5m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251636\" data-ts=\"1489666757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFN\" target=\"_blank\">INFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251636-infinera-upgraded-to-buy-goldman-sachsplus-3_96\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinera upgraded to Buy at Goldman Sachs; +3.96%</a></h4><ul><li>From Neutral, <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Infinera+Corp.+%28INFN%29+to+Buy/12674125.html\" target=\"_blank\">analyst Doug Clark</a> cites revenue recognition and contributions projected to materialize in Q2 2017 and into 2018 on new product introductions.</li><li>Price target from $10 to $13.50. Infinera (NASDAQ:<a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a>) $10.76 pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251636\" data-linked=\"Infinera upgraded to Buy at Goldman Sachs; +3.96%\" data-tweet=\"$INFN - Infinera upgraded to Buy at Goldman Sachs; +3.96% https://seekingalpha.com/news/3251636-infinera-upgraded-to-buy-goldman-sachsplus-3_96?source=tweet\" data-url=\"https://seekingalpha.com/news/3251636-infinera-upgraded-to-buy-goldman-sachsplus-3_96\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251634\" data-ts=\"1489666549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JASO\" target=\"_blank\">JASO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251634-ja-solar-caps-strong-year-better-expected-q4-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JA Solar caps strong year with better than expected Q4 revenue</a></h4><ul>     <li>JA&nbsp;Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/JASO' title='JA Solar Holdings, Co., Ltd.'>JASO</a>) <font color='green'>+6.6%</font> premarket after reporting solid <a href=\"https://seekingalpha.com/news/3251567-ja-solar-holdings-eps-0_98\" target=\"_blank\">Q4 results</a>, including better than expected revenues and external shipments rising 5.5% Y/Y and 13.8% Q/Q to 1.4 GW.</li><li>The results capped a <a href=\"https://www.pv-magazine.com/2017/03/16/ja-solar-posts-16-revenue-25-shipment-year-on-year-increase-in-2016/\" target=\"_blank\">strong year</a> for the company, as revenue rose 25% Y/Y to $2.3B and 5.2 GW in shipments beat guidance.</li><li>JASO forecasts total cell and module shipments of 1.2-1.3 GW for Q1, with FY 2017 shipments of 6.0-6.5  GW, including 200-250 MW of module shipments to its  downstream projects.</li><li>JASO also plans to increase its cell capacity from 5.5 GW at year-end 2016 to 7 GW by the end of 2017, with module capacity rising to 6 GW from 5.5 GW.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251634\" data-linked=\"JA Solar caps strong year with better than expected Q4 revenue\" data-tweet=\"$JASO - JA Solar caps strong year with better than expected Q4 revenue https://seekingalpha.com/news/3251634-ja-solar-caps-strong-year-better-expected-q4-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3251634-ja-solar-caps-strong-year-better-expected-q4-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251633\" data-ts=\"1489666462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251633-pound-moves-higher-after-boe-thanks-to-one-dissenter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pound moves higher after BOE thanks to one dissenter</a></h4><ul><li>As expected, the Bank of England kept policy on hold, but unexpectedly the vote was not unanimous. One member, Kristin Forbes, <a href=\"http://www.bankofengland.co.uk/publications/Pages/news/2017/002.aspx\" target=\"_blank\">voted for an increase in</a> the bank's benchmark rate.</li><li>The news has sent the pound (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXB' title='CurrencyShares British Pound Sterling Trust ETF'>FXB</a>) higher by about 80 pips, now&nbsp;<font color='green'>up 0.4%</font>&nbsp;vs. the dollar at $1.2236. The FTSE 100 remains&nbsp;<font color='green'>up nearly 1%</font>&nbsp;on the session.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/FXB' title='CurrencyShares British Pound Sterling Trust ETF'>FXB</a>, <a href='https://seekingalpha.com/symbol/EWU' title='iShares MSCI United Kingdom ETF'>EWU</a>, <a href='https://seekingalpha.com/symbol/GBB' title='iPath GBP/USD Exchange Rate ETN'>GBB</a>, <a href='https://seekingalpha.com/symbol/EWUS' title='iShares MSCI United Kingdom Small Cap Index ETF'>EWUS</a>, <a href='https://seekingalpha.com/symbol/FKU' title='First Trust United Kingdom AlphaDex ETF'>FKU</a>, <a href='https://seekingalpha.com/symbol/DXPS' title='WisdomTree United Kingdom Hedged Equity ETF'>DXPS</a>, <a href='https://seekingalpha.com/symbol/DBUK' title='Deutsche X-trackers MSCI United Kingdom Hedged Equity ETF'>DBUK</a>, <a href='https://seekingalpha.com/symbol/QGBR' title='SPDR MSCI United Kingdom Quality Mix ETF'>QGBR</a>, <a href='https://seekingalpha.com/symbol/HEWU' title='iShares Currency Hedged MSCI United Kingdom ETF'>HEWU</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251633\" data-linked=\"Pound moves higher after BOE thanks to one dissenter\" data-tweet=\"$FXB $EWU $GBB - Pound moves higher after BOE thanks to one dissenter https://seekingalpha.com/news/3251633-pound-moves-higher-after-boe-thanks-to-one-dissenter?source=tweet\" data-url=\"https://seekingalpha.com/news/3251633-pound-moves-higher-after-boe-thanks-to-one-dissenter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251624\" data-ts=\"1489666035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251624-ptc-acquires-dmd-med-emflaza-from-marathon-pharma-for-up-to-190m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PTC acquires DMD med Emflaza from Marathon Pharma for up to $190M</a></h4><ul><li>PTC Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a>) inks an <a href=\"https://seekingalpha.com/pr/16773000-ptc-therapeutics-announces-agreement-acquire-emflaza-treatment-duchenne-muscular-dystrophy-u\" target=\"_blank\">agreement </a>with privately held Marathon Pharmaceuticals, LLC to acquire all rights to Emflaza (deflazacort), approved last month by the FDA to treat Duchenne muscular dystrophy &#40;DMD&#41;.</li><li>Under the terms of the asset purchase agreement, PTC will pay Marathon $140M upfront ($75M in cash + $65M in PTC common stock) and annual sales-based payments (low-to-mid-twenty percent) beginning in 2018. Marathon also has the opportunity to receive a single $50M sales-based milestone.</li><li>PTC says the deal, expected to close in Q2, will be accretive to earnings and cash flow beginning in 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3242558-marathon-pharma-prices-dmd-med-deflazacort-70x-higher-ex-u-s-price\" target=\"_blank\">Marathon Pharma prices DMD med deflazacort 70x higher than ex-U.S. price</a> (Feb. 10)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3242216-fda-oks-anti-inflammatory-med-treat-duchenne-muscular-dystrophy\" target=\"_blank\">FDA OKs an anti-inflammatory med to treat Duchenne muscular dystrophy</a> (Feb. 9)</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>6%</font>&nbsp;premarket on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251624\" data-linked=\"PTC acquires DMD med Emflaza from Marathon Pharma for up to $190M\" data-tweet=\"$PTCT - PTC acquires DMD med Emflaza from Marathon Pharma for up to $190M https://seekingalpha.com/news/3251624-ptc-acquires-dmd-med-emflaza-from-marathon-pharma-for-up-to-190m?source=tweet\" data-url=\"https://seekingalpha.com/news/3251624-ptc-acquires-dmd-med-emflaza-from-marathon-pharma-for-up-to-190m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251610\" data-ts=\"1489664882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251610-emerging-markets-cheer-fed-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Emerging markets cheer Fed move</a></h4><ul><li>The MSCI Index of emerging market stocks is<font color='green'> up 2%&nbsp;</font>for the first time since July, according to Bloomberg.</li><li>The party comes after the Fed yesterday hiked rates, but otherwise sent a fairly dovish message, sending bond yields and the dollar lower.</li><li><a href='https://seekingalpha.com/symbol/EEM' title='iShares MSCI Emerging Markets ETF'>EEM</a>&nbsp;<font color='green'>+0.55%&nbsp;</font>premarket</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EEM' title='iShares MSCI Emerging Markets ETF'>EEM</a>, <a href='https://seekingalpha.com/symbol/VWO' title='Vanguard FTSE Emerging Markets ETF'>VWO</a>, <a href='https://seekingalpha.com/symbol/EDC' title='Direxion Daily Emerging Markets Bull 3x Shares ETF'>EDC</a>, <a href='https://seekingalpha.com/symbol/EDZ' title='Direxion Daily Emerging Markets Bear 3x Shares ETF'>EDZ</a>, <a href='https://seekingalpha.com/symbol/SCHE' title='Schwab Emerging Markets ETF'>SCHE</a>, <a href='https://seekingalpha.com/symbol/IEMG' title='iShares Core MSCI Emerging Markets ETF'>IEMG</a>, <a href='https://seekingalpha.com/symbol/EMF' title='Templeton Emerging Markets Fund'>EMF</a>, <a href='https://seekingalpha.com/symbol/MSF' title='Morgan Stanley Emerging Markets Fund'>MSF</a>, <a href='https://seekingalpha.com/symbol/EEV' title='ProShares UltraShort MSCI Emerging Markets ETF'>EEV</a>, <a href='https://seekingalpha.com/symbol/EUM' title='ProShares Short MSCI Emerging Markets ETF'>EUM</a>, <a href='https://seekingalpha.com/symbol/ADRE' title='BLDRS Emerging Markets 50 ADR Index ETF'>ADRE</a>, <a href='https://seekingalpha.com/symbol/EET' title='ProShares Ultra MSCI Emerging Markets ETF'>EET</a>, <a href='https://seekingalpha.com/symbol/GMM' title='SPDR S&P Emerging Markets ETF'>GMM</a>, <a href='https://seekingalpha.com/symbol/DBEM' title='Deutsche X-trackers MSCI Emerging Markets Hedged Equity ETF'>DBEM</a>, <a href='https://seekingalpha.com/symbol/EEME' title='iShares MSCI Emerging Markets EMEA Index ETF'>EEME</a>, <a href='https://seekingalpha.com/symbol/EMCR' title='Columbia Emerging Markets Core ETF'>EMCR</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3251380-stocks-bonds-gold-turn-higher-rate-hike-dollar-moves-south\" target=\"_blank\">Stocks, bonds, gold turn higher after rate hike; dollar moves south</a> (March 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3251610\" data-linked=\"Emerging markets cheer Fed move\" data-tweet=\"$EEM $VWO $EDC - Emerging markets cheer Fed move https://seekingalpha.com/news/3251610-emerging-markets-cheer-fed-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3251610-emerging-markets-cheer-fed-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251607\" data-ts=\"1489664604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIRT\" target=\"_blank\">VIRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251607-virtu-confirms-offer-for-kcg-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Virtu confirms offer for KCG Holdings</a></h4><ul><li>Though not disclosing any details, Virtu Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/VIRT' title='Virtu Financial, Inc.'>VIRT</a>) does confirm it's made <a href=\"https://seekingalpha.com/pr/16772977-virtu-releases-statement\" target=\"_blank\">non-binding proposal</a> for KCG Holdings (NYSE:<a href='https://seekingalpha.com/symbol/KCG' title='KCG Holdings, Inc.'>KCG</a>).</li><li>KCG is&nbsp;<font color='green'>higher by another 3.55%</font>&nbsp;premarket to $17.50. The stock&nbsp;<font color='green'>soared 23%</font>&nbsp;at the close yesterday on a report Virtu had offered $18 per share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251607\" data-linked=\"Virtu confirms offer for KCG Holdings\" data-tweet=\"$VIRT $VIRT $KCG - Virtu confirms offer for KCG Holdings https://seekingalpha.com/news/3251607-virtu-confirms-offer-for-kcg-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3251607-virtu-confirms-offer-for-kcg-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251604\" data-ts=\"1489664240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTBX\" target=\"_blank\">HTBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251604-heat-biologics-gets-delisting-notice-from-nasdaq-related-to-low-bid-price-investors-part\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heat Biologics gets delisting notice from Nasdaq related to low bid price, investors do their part, shares up 19% premarket</a></h4><ul><li>Heat Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a>) <a href=\"https://seekingalpha.com/filing/3462560\" target=\"_blank\">receives a delisting notice</a> from Nasdaq for failing to comply with its minimum bid price of $1. The company has 180 days to address the issue which can be done with a reverse split of its common shares, if necessary.</li><li>Shares are up&nbsp;<font color='green'>19%</font>&nbsp;to $1.10 premarket on average volume. Shares jumped a couple of days ago on positive results from an early-stage study of HS-110. Shares touched $1.25 but could not hold onto the gain.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250573-heat-biologics-advances-hsminus-110-phase-2-development-shares-jump-56-percent-premarket\" target=\"_blank\">Heat Biologics advances HS-110 to Phase 2 development; shares jump 56% premarket</a> (March 13)</li><li><strong>Update</strong>: The Florida Department of Health has awarded a ~$982K three-year grant to a University of Miami researcher to help advance a gp96-based Zika vaccine, currently being developed under a collaboration between the university and Heat's wholly-owned subsidiary Zolovax. Source: StreetInsider.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251604\" data-linked=\"Heat Biologics gets delisting notice from Nasdaq related to low bid price, investors do their part, shares up 19% premarket\" data-tweet=\"$HTBX - Heat Biologics gets delisting notice from Nasdaq related to low bid price, investors do their part, shares up 19% premarket https://seekingalpha.com/news/3251604-heat-biologics-gets-delisting-notice-from-nasdaq-related-to-low-bid-price-investors-part?source=tweet\" data-url=\"https://seekingalpha.com/news/3251604-heat-biologics-gets-delisting-notice-from-nasdaq-related-to-low-bid-price-investors-part\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251588\" data-ts=\"1489663087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DG\" target=\"_blank\">DG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251588-dollar-general-battles-through-retail-pressure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar General battles through retail pressure</a></h4><ul> <li>Dollar General (NYSE:<a href='https://seekingalpha.com/symbol/DG' title='Dollar General Corporation'>DG</a>) reports comparable sales increased 1.0% in <a href=\"https://seekingalpha.com/pr/16772926-dollar-general-reports-fourth-quarter-fiscal-2016-financial-results-company-provides\" target=\"_blank\">Q4</a> to top the consensus estimate for a 0.3% gain. Strength in the consumables and home products categories is cited.</li> <li>Gross margin came in at 31.6% of sales vs. 31.3% consensus and 31.8% a year ago.</li> <li>The company paid an effective tax rate of 36.8% in the quarter, compared to 36.1% a year ago.</li> <li>Merchandise inventories fell 0.7% on a per-store basis to $3.26B.</li> <li>The retailer sees 2017 revenue growth of 4% to 6% and 2017 EPS of $4.24-$4.50 vs. $4.67 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3251572-dollar-general-beats-0_08-beats-revenue\" target=\"_blank\">Dollar General beats by $0.08, beats on revenue</a> (March 16)</li> <li>Shares of Dollar General are <font color='green'>up 3.83</font>% premarket to $75.60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251588\" data-linked=\"Dollar General battles through retail pressure\" data-tweet=\"$DG - Dollar General battles through retail pressure https://seekingalpha.com/news/3251588-dollar-general-battles-through-retail-pressure?source=tweet\" data-url=\"https://seekingalpha.com/news/3251588-dollar-general-battles-through-retail-pressure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251572\" data-ts=\"1489661825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DG\" target=\"_blank\">DG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251572-dollar-general-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar General beats by $0.08, beats on revenue</a></h4><ul><li>Dollar General (NYSE:<a href='https://seekingalpha.com/symbol/DG' title='Dollar General Corporation'>DG</a>): Q4 EPS of $1.49 <font color='green'>beats by $0.08</font>.</li><li>Revenue of $6.00B (+13.4% Y/Y) <font color='green'>beats by $20M</font>.</li><li>Shares <font color='green'>+2.9%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16772926-dollar-general-reports-fourth-quarter-fiscal-2016-financial-results-company-provides'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251572\" data-linked=\"Dollar General beats by $0.08, beats on revenue\" data-tweet=\"$DG - Dollar General beats by $0.08, beats on revenue https://seekingalpha.com/news/3251572-dollar-general-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3251572-dollar-general-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":66,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}